Compound ID | 1441
Synonym(s): TP2758 | TP 2758
Class: Tetracycline
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against tetracycline-resistant Enterobacteriaceae, also shows activity against Gram-positive bacteria |
| Institute where first reported: | Tetraphase (Watertown, MA, USA) |
| Year first mentioned: | 2011 |
| Highest development stage: | Phase 1 (Eudract number 2011-001204-35) |
| Development status: | Active |
| Reason dropped: | Results unavailable (removed from company pipeline; Tetraphase was alter acquired by La Jolla Pharmaceutical Company in 2020) |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/134955483 |
| Citations: |
|